Germany Covid-19 Vaccine Market - Forecast(2024 - 2030)
1. Covid-19 Vaccine Production Details in Germany
1.1. No. of German Sites for Covid-19 vaccines by Type
1.2. No. of Covid-19 Vaccine Production facilities in Germany by Production Type
1.3. No. of Covid-19 Vaccine Production facilities in Germany by Vaccine Developer
2. Covid-19 Vaccines Price per dose in Germany by Vaccine Type (US$)
3. Covid-19 Vaccine Compositions of Germany by Vaccine Type
4. Covid-19 Vaccination Details in Germany 2021-2022
4.1. First Covid-19 Vaccination Dates by Vaccine Type Equivalent to Start/Launch date in Germany
4.2. Covid-19 Vaccines Administration Percentages of fully Vaccinated People by Vaccine Type in Germany 2021-2022
4.3. Covid-19 Cumulative Vaccination Doses by Type of Vaccines in Germany 2021-2022
4.4. Covid-19 Pfizer BioNTech-Comirnaty Cumulative Vaccination in Germany 2021-2022
4.5. Covid-19 Moderna-Spikevax Cumulative Vaccination in Germany 2021-2022
4.6. Covid-19 AstraZeneca-Vaxzevria Cumulative Vaccination in Germany 2021-2022
4.7. Covid-19 Janssen-Ad26.COV2.S Cumulative Vaccination in Germany 2021-2022
4.8. Covid-19 First Dose Cumulative Vaccination in Germany 2021-2022
4.9. Covid-19 Second Dose Cumulative Vaccination in Germany 2021-2022
4.10. Covid-19 Booster Dose Cumulative Vaccination in Germany 2021-2022
4.11. No. of People Vaccinated Fully by State in Germany (Million)
4.12. No. of People Vaccinated fully by Proportion of the Population by State in Germany (%)
4.13. No. of People Vaccinated at least once by State in Germany (Million)
4.14. No. of People Vaccinated at least once by Proportion of the Population by State in Germany (%)
4.15. No. of People Vaccinated with boosters by State in Germany (Million)
4.16. No. of People Vaccinated with boosters by Proportion of the Population by State in Germany (%)
4.17. Covid-19 Total Vaccinations Administered by No. of People in Germany 2021-2022 (Million)
4.18. Covid-19 Total Vaccinations Administered by Proportion of the Population in Germany 2021-2022 (%)
5. Covid-19 Funding by Germany 2020-2021
5.1. Covid-19 Funding Contribution by Germany by Pillar 2020-2021 (US$ Million)
5.2. Covid-19 Funding Percentage Contribution by Germany by Pillar 2020-2021 (%)
5.3. Germany's Value in Top Covid-19 R&D investments on Vaccines (US$ Billion)
6. Covid-19 Vaccine Doses Sharing/Donations
6.1. Covid-19 Vaccine Doses Sharing Through COVAX by Germany (Million Doses)
6.2. Covid-19 Vaccine Donations by Germany 2021 (Million Doses)
7. Covid-19 Critical Products Trade
7.1. Top3 Imports of Covid-19 Critical Products to Germany for first half of the year 2020 (US$ Million)
7.2. Top3 Imports Growth Rate (%) of Covid-19 Critical Products to Germany for first half of the year 2020
7.3. Share (%) of Top3 Imports of Total Covid-19 Critical Products to Germany for first half of the year 2020
7.4. Top2 Exports of Covid-19 Critical Products from Germany for first half of the year 2020 (US$ Million)
7.5. Top2 Exports Growth Rate (%) of Covid-19 Critical Products from Germany for first half of the year 2020
7.6. Share (%) of Top2 Exports of Total Covid-19 Critical Products from Germany for first half of the year 2020
7.7. Germany’s Value in World's Top Exporters of Covid-19 Critical Products during the first half of 2020 (US$ Million)
7.8. Germany’s Growth Rate (%) Value in World's Top Exporters of Covid-19 Critical Products during the first half of 2020
7.9. Germany’s Value Share (%) of World's Top Exporters of Covid-19 Critical Products during the first half of 2020
7.10. Germany’s Value in World's Top Importers of Covid-19 Critical Products during the first half of 2020 (US$ Million)
7.11. Germany’s Growth Rate (%) Value in World's Top Importers of Covid-19 Critical Products during the first half of 2020
7.12. Germany’s Share (%) of World's Top Importers of Covid-19 Critical Products during the first half of 2020
7.13. Germany's Value in Importing Face Masks from China during the first half of 2020 (US$ Million)
7.14. Germany's Share (%) in Importing Face Masks from China during the first half of 2020
8. Covid-19 Cases in Germany 2020-2022
8.1. Arrival of First Covid-19 Variants Equivalent to First Case in Germany
8.2. Covid-19 No. of Cases in Germany 2020-2022
8.3. Covid-19 Cases Growth Rate (%) in Germany 2020-2022
8.4. Covid-19 Cumulative Cases in Germany 2020-2022
8.5. Covid-19 Cases by Age Group and Gender in Germany 2020-2022
8.6. Covid-19 Cases by Age Group and Sex/100,000 population in Germany 2020-2022
8.7. Covid-19 Cases by Federal State in Germany 2020-2022
9. No. of People Hospitalized due to Covid-19 by Age Group in Germany 2020-2022
10. Prevalence of Covid-19 Disease in Germany 2020-2022
10.1. Prevalence Rate (%) of Covid-19 Disease in Germany 2020-2022
10.2. Cumulative Prevalence Rate (%) of Covid-19 Disease in Germany 2020-2022
10.3. Prevalence Rate (%) Status of Covid-19 Disease and Covid-19 Deaths in Germany
11. Covid-19 Test Kits and Surgical Masks in Germany
11.1. Covid-19 Major Diagnostic Test Kits Manufacturers of Germany
11.2. Major Surgical Mask Manufacturers in Germany
12. Covid-19 Mortality Rate in Germany 2020-2022
12.1. Covid-19 Deaths in Germany 2020-2022
12.2. Covid-19 Deaths Growth Rate (%) in Germany 2020-2022
12.3. Covid-19 Cumulative Deaths in Germany 2020-2022
12.4. Covid-19 Deaths by Age Group and Gender in Germany 2020-2022
12.5. Covid-19 Deaths by Age Group and Sex/100,000 population in Germany 2020-2022
12.6. Covid-19 Deaths by Federal State in Germany 2020-2022
12.7. Covid-19 Fatality Rate (%) in Germany 2020-2022
13. Covid-19 Impact on GDP in Germany 2020-2021
13.1. Covid-19 Effect on GDP Change (%) in Germany 2020-2021
13.2. Covid-19 Effect on GDP Change (%) on Previous Quarter in Germany 2020-2021
13.3. Covid-19 Effect on GDP Change (%) on Same Quarter a year earlier in Germany 2020-2021
14. Covid-19 Clinical Trials in Germany 2019-2022
14.1. No. of Clinical trials of Covid-19 in Germany 2019-2022
14.2. No. of Clinical trials of Covid-19 in Germany by Phases 2019-2022
14.3. Percentage (%) of Clinical trials of Covid-19 in Germany by Age 2019-2022
14.4. Percentage (%) of Clinical trials of Covid-19 in Germany by Gender 2019-2022
14.5. No. of Clinical trials of Covid-19 in Germany by Funding Type 2019-2022
14.6. No. of Clinical trials of Covid-19 in Germany by Status 2019-2022
14.7. No. of Clinical trials of Covid-19 in Germany by Study Type 2019-2022
14.8. No. of Clinical trials of Covid-19 in Germany by Study Documents 2019-2022
15. Covid-19 Vaccine Clinical Trials in Germany 2020-2022
15.1. Covid-19 Vaccines Approved for Use in Germany 2020-2022
15.2. Clinical Trials on Covid-19 Vaccines by Vaccine Type in Germany 2020-2022
15.3. Ongoing Clinical Trials on Covid-19 Vaccines and its Status in Germany 2020-2022
16. Covid-19 Patents in Germany 2019-2022
16.1. Covid-19 Patent documents by Type in Germany 2019-2022
16.2. Covid-19 Patent Legal Status in Germany2019-2022
16.3. Covid-19 Patent documents by Published, Filed and Granted Date in Germany 2019-2022
16.4. Covid-19 Patent documents by Published Date in Germany 2019-2022
16.5. Covid-19 Patent documents by Filing Date in Germany 2019-2022
16.6. Covid-19 Patent documents by Granted Date in Germany 2019-2022
16.7. Covid-19 Major Applicants in Germany 2019-2022
16.8. Covid-19 Major Inventors in Germany 2019-2022
16.9. Covid-19 Patents and its Details in Germany 2019-2022
17. University Project Analysis of Covid-19 in Germany
17.1. Covid-19 University Level Studies by year in Germany 2020-2022
17.2. Covid-19 University Level Studies by Publication Type in Germany 2020-2022
17.3. Top Publishers of Covid-19 University Level Studies by Document Count in Germany 2020-2022
17.4. Type of Funding in University Level Studies of Covid-19 in Germany 2020-2022 (%)
18. Covid-19 Testing Rates in Germany 2020-2021
18.1. Covid-19 Testing Rate (%) in Proportion of Population in Germany 2020-2021
18.2. Covid-19 Positivity Rate (%) in Germany 2020-2021
19. Covid-19 Key Trends in Germany 2020-2022